PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. (Q46229463)
Jump to navigation
Jump to search
scientific article published on 28 November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. |
scientific article published on 28 November 2014 |
Statements
PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells (English)
Vihren N Kolev
Christian M Vidal
Jennifer E Ring
Irina M Shapiro
Jill Ricono
David T Weaver
Mahesh V Padval
Jonathan A Pachter
28 November 2014